Moderna Brass Hit With Investor Suit Over RSV Shot Claims

By Emilie Ruscoe · October 28, 2024, 8:37 PM EDT

Officers and directors of Moderna face shareholder derivative allegations that they overstated how effective the company's RSV vaccine candidate was as the pharmaceutical giant sought regulatory permission to expedite its development....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

Chislock v. Bancel et al

Case Number

1:24-cv-12722

Court

Massachusetts

Nature of Suit

Securities/Commodities

Date Filed

October 28, 2024